Gene · 23521
Papers2,970
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,970
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Natural variation in gene expression and viral susceptibility revealed by neural progenitor cell villages. | Cell Stem Cell | 2023 | 36796362 | PubTator, text mining | PubMed |
| PARP1 associates with R-loops to promote their resolution and genome stability. | Nucleic Acids Res | 2023 | 36794853 | PubTator, text mining | PubMed |
| Integrative analysis of the expression profiles of whole coding and non-coding RNA transcriptomes and construction of the competing endogenous RNA networks for chronic obstructive pulmonary disease. | Front Genet | 2023 | 36793900 | PubTator, text mining | PubMed |
| Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer. | Nat Commun | 2023 | 36788224 | PubTator, text mining | PubMed |
| Genetic Variant Overlap Analysis Identifies Established and Putative Genes Involved in Pulmonary Fibrosis. | Int J Mol Sci | 2023 | 36769106 | PubTator, text mining | PubMed |
| Disintegration of the NuRD Complex in Primary Human Muscle Stem Cells in Critical Illness Myopathy. | Int J Mol Sci | 2023 | 36769095 | PubTator, text mining | PubMed |
| The Effects of the Follicle-Stimulating Hormone on Human Follicular Fluid-Derived Stromal Cells. | Int J Mol Sci | 2023 | 36768772 | PubTator, text mining | PubMed |
| An Overview: Genetic Tumor Markers for Early Detection and Current Gene Therapy Strategies. | Cancer Inform | 2023 | 36762284 | PubTator, text mining | PubMed |
| Noncanonical regulation of imprinted gene Igf2 by amyloid-beta 1-42 in Alzheimer's disease. | Sci Rep | 2023 | 36739453 | PubTator, text mining | PubMed |
| Establishment and characterization of canine mammary tumoroids for translational research. | BMC Biol | 2023 | 36737789 | PubTator, text mining | PubMed |
| Systemic deuteration of SCID mice using the water-isotopologue deuterium oxide (D2 O) inhibits tumor growth in an orthotopic bioluminescent model of human pancreatic ductal adenocarcinoma. | Mol Carcinog | 2023 | 36727657 | PubTator, text mining | PubMed |
| Sequential genome-wide CRISPR-Cas9 screens identify genes regulating cell-surface expression of tetraspanins. | Cell Rep | 2023 | 36724073 | PubTator, text mining | PubMed |
| Sumoylation is Largely Dispensable for Normal Growth but Facilitates Heat Tolerance in Yeast. | Mol Cell Biol | 2023 | 36720466 | PubTator, text mining | PubMed |
| Targeting GSTP1 as Therapeutic Strategy against Lung Adenocarcinoma Stemness and Resistance to Tyrosine Kinase Inhibitors. | Adv Sci (Weinh) | 2023 | 36709476 | PubTator, text mining | PubMed |
| Precise transcript targeting by CRISPR-Csm complexes. | Nat Biotechnol | 2023 | 36690762 | PubTator, text mining | PubMed |
| Urokinase System in Pathogenesis of Pulmonary Fibrosis: A Hidden Threat of COVID-19. | Int J Mol Sci | 2023 | 36674896 | PubTator, text mining | PubMed |
| Essential Role of Adhesion GPCR, GPR123, for Human Pluripotent Stem Cells and Reprogramming towards Pluripotency. | Cells | 2023 | 36672239 | PubTator, text mining | PubMed |
| Loss of the crumbs cell polarity complex disrupts epigenetic transcriptional control and cell cycle progression in the developing retina. | J Pathol | 2023 | 36656098 | PubTator, text mining | PubMed |
| Clustering by antigen-presenting genes reveals immune landscapes and predicts response to checkpoint immunotherapy. | Sci Rep | 2023 | 36653470 | PubTator, text mining | PubMed |
| Short- and long-term polystyrene nano- and microplastic exposure promotes oxidative stress and divergently affects skin cell architecture and Wnt/beta-catenin signaling. | Part Fibre Toxicol | 2023 | 36647127 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23521/papers?page=14